These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 12667686)

  • 1. Generation of recombinant human monoclonal antibodies to rotavirus from single antigen-specific B cells selected with fluorescent virus-like particles.
    Weitkamp JH; Kallewaard N; Kusuhara K; Feigelstock D; Feng N; Greenberg HB; Crowe JE
    J Immunol Methods; 2003 Apr; 275(1-2):223-37. PubMed ID: 12667686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural evolution of a human virus-specific antibody gene repertoire by somatic hypermutation requires both hotspot-directed and randomly-directed processes.
    Weitkamp JH; Lafleur BJ; Greenberg HB; Crowe JE
    Hum Immunol; 2005 Jun; 66(6):666-76. PubMed ID: 15993712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human monoclonal Fab fragments against rotavirus from phage display combinatorial libraries.
    Itoh K; Nakagomi O; Suzuki K; Inoue K; Tada H; Suzuki T
    J Biochem; 1999 Jan; 125(1):123-9. PubMed ID: 9880807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rotavirus-specific CD5+ B cells in young children exhibit a distinct antibody repertoire compared with CD5- B cells.
    Weitkamp JH; Lafleur BJ; Crowe JE
    Hum Immunol; 2006; 67(1-2):33-42. PubMed ID: 16698423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infant and adult human B cell responses to rotavirus share common immunodominant variable gene repertoires.
    Weitkamp JH; Kallewaard N; Kusuhara K; Bures E; Williams JV; LaFleur B; Greenberg HB; Crowe JE
    J Immunol; 2003 Nov; 171(9):4680-8. PubMed ID: 14568943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and reliable cloning of antibody variable regions and generation of recombinant single chain antibody fragments.
    Gilliland LK; Norris NA; Marquardt H; Tsu TT; Hayden MS; Neubauer MG; Yelton DE; Mittler RS; Ledbetter JA
    Tissue Antigens; 1996 Jan; 47(1):1-20. PubMed ID: 8929708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and molecular characterization of the cDNAs encoding the variable regions of an anti-CD20 monoclonal antibody.
    Shanehbandi D; Majidi J; Kazemi T; Baradaran B; Aghebati-Maleki L
    Hum Antibodies; 2017; 26(1):1-6. PubMed ID: 28269762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-phase approach for the expression of high-affinity human anti-human immunodeficiency virus immunoglobulin Fab domains in Escherichia coli.
    Takeda S; Dorfman NA; Robert-Guroff M; Notkins AL; Rando RF
    Hybridoma; 1995 Feb; 14(1):9-18. PubMed ID: 7768538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, sequencing and expression of the Fab fragment of a monoclonal antibody to the herbicide atrazine.
    Ward VK; Schneider PG; Kreissig SB; Hammock BD; Choudary PV
    Protein Eng; 1993 Nov; 6(8):981-8. PubMed ID: 8309947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of two human recombinant monoclonal Fab fragments specific for EBV viral capsid antigen.
    Dong L; Masaki Y; Takegami T; Kawanami T; Itoh K; Jin ZX; Huang CR; Tong XP; Fukushima T; Tanaka M; Sawaki T; Sakai T; Sugai S; Okazaki T; Hirose Y; Umehara H
    Int Immunol; 2007 Mar; 19(3):331-6. PubMed ID: 17272286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant human Fab expressed in Escherichia coli neutralizes rabies virus.
    Cheung SC; Dietzschold B; Koprowski H; Notkins AL; Rando RF
    J Virol; 1992 Nov; 66(11):6714-20. PubMed ID: 1404611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting monoclonal antibodies into Fab fragments for transient expression in mammalian cells.
    Nettleship JE; Flanagan A; Rahman-Huq N; Hamer R; Owens RJ
    Methods Mol Biol; 2012; 801():137-59. PubMed ID: 21987252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody generation through B cell panning on antigen followed by in situ culture and direct RT-PCR on cells harvested en masse from antigen-positive wells.
    Lightwood DJ; Carrington B; Henry AJ; McKnight AJ; Crook K; Cromie K; Lawson AD
    J Immunol Methods; 2006 Oct; 316(1-2):133-43. PubMed ID: 17027850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralizing human Fab fragments against measles virus recovered by phage display.
    de Carvalho Nicacio C; Williamson RA; Parren PW; Lundkvist A; Burton DR; Björling E
    J Virol; 2002 Jan; 76(1):251-8. PubMed ID: 11739690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones.
    Tian C; Luskin GK; Dischert KM; Higginbotham JN; Shepherd BE; Crowe JE
    J Immunol; 2008 Mar; 180(5):3279-88. PubMed ID: 18292552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and characterization of human group C rotavirus virus-like particles in insect cells.
    Clark KB; Lin SC; Humphrey C; Foytich K; Esona M; Wang Y; Liu M; Jiang B
    Virology; 2009 May; 387(2):267-72. PubMed ID: 19285329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus.
    Liang M; Chu YK; Schmaljohn C
    Virology; 1996 Mar; 217(1):262-71. PubMed ID: 8599211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotavirus capsid VP6 tubular and spherical nanostructures act as local adjuvants when co-delivered with norovirus VLPs.
    Malm M; Heinimäki S; Vesikari T; Blazevic V
    Clin Exp Immunol; 2017 Sep; 189(3):331-341. PubMed ID: 28407442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant monoclonal antibody technology.
    Siegel DL
    Transfus Clin Biol; 2002 Jan; 9(1):15-22. PubMed ID: 11889896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.
    Cheng XJ; Hayasaka H; Watanabe K; Tao YL; Liu JY; Tsukamoto H; Horii T; Tanabe K; Tachibana H
    Infect Immun; 2007 Jul; 75(7):3614-20. PubMed ID: 17452466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.